Novel Immunotherapies and Combinations

(25:34)

New Approaches with Immunotherapies and Breast Cancer

(1:2:45)

Immunotherapies and Immune-Related Toxicities

(4:45)

Emerging Immunotherapies and Combinations for NSCLC

(3:46)

Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology

(26:32)

What is CAR T-cell therapy? | Epworth Centre for Immunotherapies and Snowdome Laboratories

(3:8)

Shaping the Future of Emerging Immunotherapies and Cell Therapies

(56:31)

Breakthrough Cancer Treatments: How Immunotherapy is Saving Lives | MediGence

(3:52)

Dr. Pamela Kunz on the Effectiveness of Immunotherapies and Their Promising Future

(1:1econd)

Combination immunotherapies and multi-modal treatment

(6:14)

Novel Immunotherapies and Combinations

(25:34)

Emerging data on immunotherapies and tyrosine kinase inhibitors in lung cancer: 2022 ESMO Florida

(30)

Louise Perkins - A Case Study for Immunotherapies and Targeted Therapies

(57:27)

Navigating Immunotherapies and Combinations in the Search for the Best Strategy for Each Patient

(1:25:42)

Immunotherapies and GI Cancer

(58)

Translating Progress With Immunotherapies and Targeted Agents Into Improved Outcomes in TNBC

(57:18)

Future Immunotherapies and Neuroprotective therapies

(42:39)

Barbara Burtness, MD, discusses immunotherapies and treatment of head and neck cancers

(2:57)

The patient experience - Epworth Centre for Immunotherapies and Snowdome Laboratories

(3:27)

Epworth Centre for Immunotherapies and Snowdome Laboratories | Stem Cell Transplant

(4:19)